Gregory A. Maglinte, Ph.D.

Affiliations: 
2009 University of California, Los Angeles, Los Angeles, CA 
Area:
Public Health, Health Care Management, Psychometrics Psychology
Google:
"Gregory Maglinte"
Cross-listing: PHTree

Parents

Sign in to add mentor
Robert M. Kaplan grad student 2009 UCLA
 (Generic health -related quality of life measures in the National Health Measurement Study: Comparing different preference-based scores and deriving U.S. general population norms for the SF -36v2.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Graham CN, Maglinte GA, Schwartzberg LS, et al. (2016) Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-Type KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy. Clinical Therapeutics
Velligan DI, Mintz J, Sierra C, et al. (2015) The Daily Activity Report (DAR) a Novel Measure of Functional Outcome for Serious Mental Illness. Schizophrenia Bulletin
Wang J, Hechmati G, Dong J, et al. (2015) Q-TWiST analysis of panitumumab plus FOLFOX4 versus FOLFOX4 alone in patients with previously untreated wild-type RAS metastatic colorectal cancer. Current Medical Research and Opinion. 1-22
Graham CN, Hechmati G, Fakih MG, et al. (2015) Cost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-type RAS metastatic colorectal cancer. Journal of Medical Economics. 1-10
Coritsidis GN, Maglinte GA, Acharya A, et al. (2014) Anemia management trends in hospital-based dialysis centers (HBDCs), 2010 to 2013. Clinical Therapeutics. 36: 408-18
Gaweda AE, Bhat P, Maglinte GA, et al. (2014) TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patients. Hemodialysis International. International Symposium On Home Hemodialysis. 18: 38-46
Blumenfeld AM, Bloudek LM, Becker WJ, et al. (2013) Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 53: 644-55
Rendas-Baum R, Bloudek LM, Maglinte GA, et al. (2013) The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 22: 1123-33
Maglinte GA, Hays RD, Kaplan RM. (2012) US general population norms for telephone administration of the SF-36v2. Journal of Clinical Epidemiology. 65: 497-502
Bagley CL, Rendas-Baum R, Maglinte GA, et al. (2012) Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache. 52: 409-21
See more...